Pharmaceuticals
Sanofi to buy Biogen hemophilia spinoff for $11.6 billion | Bloomberg
Sanofi is buying Bioverativ, the largest acquisition for Sanofi in seven years. The deal will connect Sanofi to hemophilia doctors and patients.
Shares of biotech Juno, already up 50% on deal hopes, skyrocket on actual Celgene $9 billion offer | CNBC
Celgene will spend $9 billion to buy the portion of Juno Therapeutics it doesn't yet own. The purchase will bring Celgene Juno's pipeline of CAR-T cancer medications.
Information technology
Zipongo raises $18M to bring food prescription app for chronic conditions to providers, health plans | Medcity News
Zipongo's FoodScripts app gives people with hypertension, diabetes, and obesity nutrition advice. Ziponogo will use the funding to introduce the app, first through a pilot program that will begin in a few months.
Blue Cross Blue Shield of Arizona teams up with American Well for telemedicine options | Mobihealthnews
Blue Cross Blue Shield of Arizona and American Well are introducing the BlueCare Anywhere program for telehealth via mobile device.
In other news
1 son, 4 overdoses, 6 hours | The New York Times
Most drug users do not die from overdoses. This is the story of one of those people, who guesses he's overdosed about 30 times.
